BiotechTube

Darexaban + Acetyl Salicylic Acid (ASA)

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacodynamic and Pharmacokinetic Interaction

Conditions

Pharmacodynamic and Pharmacokinetic Interaction, Healthy Subjects

Trial Timeline

Dec 1, 2007 → Mar 1, 2008

NCT ID
NCT01424332

About Darexaban + Acetyl Salicylic Acid (ASA)

Darexaban + Acetyl Salicylic Acid (ASA) is a phase 1 stage product being developed by Astellas Pharma for Pharmacodynamic and Pharmacokinetic Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT01424332. Target conditions include Pharmacodynamic and Pharmacokinetic Interaction, Healthy Subjects.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01424332Phase 1Completed

Competing Products

10 competing products in Pharmacodynamic and Pharmacokinetic Interaction

See all competitors
ProductCompanyStageHype Score
GP40141 + NplateGEROPHARMPhase 1
25
darexaban + darexaban (double dose) + Acetyl Salicylic Acid + clopidogrelAstellas PharmaPhase 1
33
darexaban + NaproxenAstellas PharmaPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
AZD9977 oral suspension + AZD9977 placebo oral suspension + Fludrocortisone, tablets + Eplerenone, tabletsAstraZenecaPhase 1
33
D961H + OmeprazoleAstraZenecaPhase 1
33
Dienogest (81150037) + Dienogest (81150231) + Dienogest (SH T00660A) + Dienogest (81150746)BayerPhase 1
30
5 mg ACT-281959 prodrug formulation I (Group A) + 20 mg ACT-281959 prodrug formulation I (Group B) + ACT-281959 prodrug formulation I (Groups C to G doses to be defined) + ACT-281959 prodrug formulation II (Group G dose to be defined) + ACT-246475 (Group G dose to be defined) + Placebo (Groups A to F)IdorsiaPhase 1
28
Vamorolone + Eplerenone + FludrocortisoneSanthera PharmaceuticalsPhase 1
25
VXA-A1.1 H1 Tablet Vaccine (small) + VXA-A1.1 H1 Tablet Vaccine (large)VaxartPhase 1
25

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85